Arkansas Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 11 (92% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 10,052
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 33.52%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,325
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 34.09%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 62.93% 61.43%
White, Hispanic/Latino Patients 7.35% 7.09%
Black/African American, Non-Hispanic/Latino Patients 18.70% 17.21%
Black/African American, Hispanic/Latino Patients 0.09% 0.23%
Asian Patients3 0.50% 0.53%
American Indian/Alaska Native Patients3 0.33% 0.45%
Native Hawaiian/Other Pacific Islander Patients3 1.11% 0.91%
Patients with More than one race3 0.89% 1.51%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.77% 3.85%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.73% 0.68%
Unreported/Refused to Report Race and Ethnicity 4.61% 6.11%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,024
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 62.39%
COVID-19 Immunization Series Completed 1,453
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 56.17%
COVID-19 Immunization Series Additional 23
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 9.09%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 34.96% 40.12% 86.96%
White, Hispanic/Latino Patients 11.91% 9.57% 4.35%
Black/African American, Non-Hispanic/Latino Patients 25.59% 30.08% 4.35%
Black/African American, Hispanic/Latino Patients 0.59% 0.07% 0.00%
Asian Patients3 1.07% 0.62% 0.00%
American Indian/Alaska Native Patients3 0.59% 0.55% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 6.15% 1.24% 0.00%
Patients with More than one race3 2.83% 3.37% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 9.28% 5.92% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.56% 1.24% 0.00%
Unreported/Refused to Report Race and Ethnicity 5.47% 7.23% 4.35%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 9.09%
1 to 24 Hours 18.18%
More Than 24 Hours 72.73%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 27.27%
Vaccine confidence 45.45%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 9.09%
None 36.36%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 111.82%
Average Percent of Health Center Visits Conducted Virtually 11.82%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 54.55%
Number of Mobile Van Sites 14
Number of Pop-up Clinics 9
Number of School-Based Vaccination Sites 6

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 45.45%
Refer patients to another organization that provides monoclonal antibody therapies 36.36%
None 27.27%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 0.00%
Therapy administration/onsite logistics 9.09%
Other 18.18%
None 72.73%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021